Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C | NEJM
Original Article from The New England Journal of Medicine — Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
Original Article from The New England Journal of Medicine — Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
A 96-year-old woman presented with a 1-day history of pleuritic chest pain 4 days after a pacemaker was implanted for complete heart block. Electrocardiography showed…
A 73-year-old woman was transferred to the hospital because of rash, leukocytosis, and eosinophilia. CT revealed a mass in the lung and diffuse lymphadenopathy. A…
The antibody that mediates the occurrence of VITT associated with adenoviral-based Covid-19 vaccines is nearly identical to the antibodies produced in response to natural adenoviral…
This feature about an attending preparing for her upcoming week of service offers a case vignette accompanied by two essays, one supporting visiting patients early…
A 73-year-old woman was transferred to the hospital because of rash, leukocytosis, and eosinophilia. CT revealed a mass in the lung and diffuse lymphadenopathy. A…
A 66-year-old man with recently diagnosed cirrhosis associated with metabolic dysfunction–associated steatohepatitis presented with a 1-day history of melena and hematemesis.
Protecting health is a team sport — yet the public health and clinical care systems meant to advance this goal have been siloed for too…
Explore the current issue of The New England Journal of Medicine (Vol. 390 No. 19).
This award recognizes an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment or…
These Clinical Oncology Research one-year fellowships of $100,000 provide clinical fellows with real-world experience in clinical development at an industry facility.